- Our LinkedIn Page
- Our Twitter Feed
- Our Facebook Page
- Newsletter Subscribe to our e-newsletter. Current Issue
- Our Flickr Feed
- Our YouTube Feed
Authors
- Abigail Hirsch
- Alan Eisenberg
- BIOtechNOW Editor
- Bruce Dale
- Celia Economides
- Colleen Lerro
- David Thomas, CFA
- George Goodno
- George MacDougall
- Jason Corum
- Jeff Joseph
- Jim Greenwood
- Karen Batra
- Kelly Cappio
- Lila Feisee
- Matt Carr
- Nathan Schock
- Paul Winters
- Paulina Ibarra
- Robbi Lycett
- Roy Zwahlen
- Sarah Sneeringer
- Sondra Behan
- Stephanie Fischer
- Stephen Marmaras
- Tracy Cooley
Tag Archives: Intellectual Property
USPTO Economic Research Agenda
The USPTO has a new Office of the Chief Economist and they have recently published their research agenda. USPTO Economic Research Agenda The OCE is embarking upon an aggressive economic research program to provide evidence on a range of matters relevant to policymaking and the effect of IP on economic outcomes more generally. These include: (1) Relating IP to economic growth, performance and employment, including: (a) IP and entrepreneurship (b) IP and wider Read More >
Secretary Sebelius speaks at biotech meeting
Secretary Sebelius delivered a speech in California yesterday which recognized the potential of biotechnology to address unmet needs in human health, agriculture and industrial and environmental applications. In her remarks, Secretary Sebelius stated: “[I]nvesting in each step of the process that starts with basic scientific discovery and ends with the development and provision of better diagnostics, treatments, and preventive strategies to significantly improve health care. I know I don’t have to tell you that because Read More >
New Blogger
Patently Biotech has a new writer. My name is Roy Zwahlen and I am the new Intellectual Property manager at BIO. I am an attorney and political science undergraduate and fascinated with intellectual property policy. I am excited about this opportunity to enter the IP blogosphere. My hope is to provide information about BIO’s IP activities including conferences and amicus briefs. I also hope to reintroduce our IP staff and spotlight our BIO company members. Read More >